Genenews Limited (GEN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 10-2024 | 07-2024 | 04-2024 | 01-2024 | 10-2023 | |
| Cash Flows From Operating Activities | |||||
| Other Working Capital | 69 | -254 | 11 | 20 | -48 |
| Other Operating Activity | -237 | -473 | -165 | -85 | -39 |
| Operating Cash Flow | $-168 | $-727 | $-154 | $-65 | $-87 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -2,110 | 286 | -23 | N/A |
| Other Investing Activity | -205 | -10 | -32 | 0 | 0 |
| Investing Cash Flow | $-205 | $-2,120 | $254 | $-23 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 2,257 | 1,400 | 0 | 0 |
| Other Financing Activity | 0 | 0 | -360 | 33 | 280 |
| Financing Cash Flow | $0 | $2,257 | $1,040 | $33 | $280 |
| Beginning Cash Position | 587 | 1,177 | 40 | 94 | 184 |
| End Cash Position | 215 | 587 | 1,182 | 40 | 94 |
| Net Cash Flow | $-373 | $-590 | $1,139 | $-54 | $-90 |
| Free Cash Flow | |||||
| Operating Cash Flow | -168 | -727 | -154 | -65 | -87 |
| Capital Expenditure | N/A | -2,110 | N/A | -23 | N/A |
| Free Cash Flow | -168 | -2,837 | -154 | -87 | -87 |